help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 3, 2005
Molecular Endocrinology, doi:10.1210/me.2005-0165
A more recent version of this article appeared on March 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data Figures
Right arrow All Versions of this Article:
20/3/573    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koyanagi, S.
Right arrow Articles by Ohdo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koyanagi, S.
Right arrow Articles by Ohdo, S.

Submitted on April 22, 2005
Accepted on October 27, 2005

Chronic treatment with prednisolone represses the circadian oscillation of clock gene expression in mouse peripheral tissues

Satoru Koyanagi, Sumako Okazawa, Yukako Kuramoto, Kentarou Ushijima, Hiroshi Shimeno, Shinji Soeda, Hitoshi Okamura, and Shigehiro Ohdo*

Department of Biochemistry, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma Jonan-ku, Fukuoka 814-0180, Japan; Pharmaceutics, Division of Clinical Pharmacy, Department of Medico-Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan; Division of Molecular Brain Science, Department of Brain Sciences, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan

* To whom correspondence should be addressed. E-mail: ohdo{at}phar.kyushu-u.ac.jp.

Although altered homeostatic regulation, including disturbance of 24-hour rhythms, is often observed in the patients undergoing glucocorticoid therapy, the mechanisms underlying the disturbance remains poorly understood. We report here that chronic treatment with a synthetic glucocorticoid, prednisolone (PSL), can cause alteration of circadian clock function at molecular level. Treatment of cultured hepatic cells (HepG2) with PSL induced expression of Period1 (Per1), and the PSL treatment also attenuated the serum-induced oscillations in the expression of Period2 (Per2), Rev-erb{alpha}, and Bmal1 mRNA in HepG2 cells. Because the attenuation of clock gene oscillations was blocked by pretreating the cells with a Per1 antisense phosphothioate oligonucleotide (ODNs), the extensive expression of Per1 induced by PSL may have resulted in the reduced amplitude of other clock gene oscillations. Continuous administration of PSL into mice constitutively increased the Per1 mRNA levels in liver and skeletal muscle, which seems to attenuate the oscillation in the expressions of Per2, Rev-erb{alpha}, and Bmal1. However, a single daily administration of PSL at the time of day corresponding to acrophase of endogenous glucocorticoid levels had little effect on the rhythmic expression of clock genes. These results suggest a possible pharmacological action by PSL on the core circadian oscillation mechanism and indicate the possibility that the alteration of clock function induced by PSL can be avoided by optimizing the dosing schedule.

NURSA Molecule Pages Link:

Nuclear Receptors:   REV-ERBα  |  GR



This article has been cited by other articles:


Home page
Eur Respir JHome page
N. Burioka, S. Koyanagi, M. Endo, M. Takata, Y. Fukuoka, M. Miyata, K. Takeda, H. Chikumi, S. Ohdo, and E. Shimizu
Clock gene dysfunction in patients with obstructive sleep apnoea syndrome
Eur. Respir. J., July 1, 2008; 32(1): 105 - 112.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Hayasaka, T. Yaita, T. Kuwaki, S. Honma, K.-i. Honma, T. Kudo, and S. Shibata
Optimization of Dosing Schedule of Daily Inhalant Dexamethasone to Minimize Phase Shifting of Clock Gene Expression Rhythm in the Lungs of the Asthma Mouse Model
Endocrinology, July 1, 2007; 148(7): 3316 - 3326.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society